XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -45.48%6.12B | -45.48%6.12B | -45.30%6.52B | -48.42%5.8B | -2.33%10.17B | 4.08%11.22B | 4.08%11.22B | 22.08%11.93B | 21.43%11.24B | 26.41%10.41B |
-Cash and cash equivalents | -55.93%4.57B | -55.93%4.57B | -52.84%5.24B | -54.88%4.58B | -1.42%9.16B | -1.28%10.37B | -1.28%10.37B | 21.14%11.11B | 16.65%10.15B | 22.23%9.29B |
-Short-term investments | 82.09%1.55B | 82.09%1.55B | 57.13%1.29B | 12.00%1.22B | -9.86%1.01B | 209.36%849.2M | 209.36%849.2M | 36.52%818M | 96.88%1.09B | 76.21%1.12B |
Receivables | 2.94%1.61B | 2.94%1.61B | 13.77%1.75B | 6.42%1.66B | 15.85%1.79B | 8.40%1.56B | 8.40%1.56B | 11.08%1.54B | 16.75%1.56B | 19.72%1.55B |
-Accounts receivable | 2.94%1.61B | 2.94%1.61B | 13.77%1.75B | 6.42%1.66B | 15.85%1.79B | 8.40%1.56B | 8.40%1.56B | 11.08%1.54B | 16.75%1.56B | 19.72%1.55B |
Inventory | 63.16%1.21B | 63.16%1.21B | 56.79%1.08B | 51.55%914.6M | 51.95%813.1M | 60.40%738.8M | 60.40%738.8M | 77.41%688.7M | 64.13%603.5M | 57.89%535.1M |
Prepaid assets | -14.58%459.2M | -14.58%459.2M | ---- | ---- | ---- | 24.56%537.6M | 24.56%537.6M | ---- | ---- | ---- |
Other current assets | -9.37%76.4M | -9.37%76.4M | -16.85%449.2M | 20.65%575.4M | 9.05%511.1M | 13.31%84.3M | 13.31%84.3M | -25.68%540.2M | -13.21%476.9M | -4.64%468.7M |
Total current assets | -32.15%9.6B | -32.15%9.6B | -33.29%9.8B | -35.55%8.94B | 2.49%13.29B | 6.87%14.14B | 6.87%14.14B | 19.76%14.7B | 20.60%13.87B | 25.14%12.97B |
Non current assets | ||||||||||
Net PPE | 77.89%2.58B | 77.89%2.58B | 75.25%2.51B | 22.40%1.77B | 2.60%1.49B | -0.20%1.45B | -0.20%1.45B | -1.84%1.43B | 2.00%1.45B | 0.81%1.45B |
-Gross PPE | 38.14%3.65B | 38.14%3.65B | 75.25%2.51B | 22.40%1.77B | 2.60%1.49B | 6.39%2.64B | 6.39%2.64B | -1.84%1.43B | 2.00%1.45B | 0.81%1.45B |
-Accumulated depreciation | 10.44%-1.06B | 10.44%-1.06B | ---- | ---- | ---- | -15.73%-1.19B | -15.73%-1.19B | ---- | ---- | ---- |
Goodwill and other intangible assets | -0.73%1.91B | -0.73%1.91B | 13.48%1.92B | 13.83%1.93B | 13.67%1.92B | 13.97%1.93B | 13.97%1.93B | 0.76%1.69B | 21.77%1.69B | 20.64%1.69B |
-Goodwill | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 0.00%1.09B | 1.19%1.09B | 8.56%1.09B | 8.56%1.09B |
-Other intangible assets | -1.67%825.9M | -1.67%825.9M | 37.77%831.6M | 38.75%837.5M | 38.32%834.9M | 39.15%839.9M | 39.15%839.9M | 0.00%603.6M | 55.97%603.6M | 50.90%603.6M |
Investments and advances | 104.50%5.11B | 104.50%5.11B | 176.68%4.7B | 223.66%4.39B | 305.12%4.38B | 2,126.20%2.5B | 2,126.20%2.5B | --1.7B | --1.36B | --1.08B |
Non current deferred assets | 28.64%2.33B | 28.64%2.33B | 33.53%2.31B | 42.11%2.19B | 44.35%1.96B | 45.33%1.81B | 45.33%1.81B | 48.71%1.73B | 34.46%1.54B | 43.83%1.36B |
Other non current assets | 11.62%999.3M | 11.62%999.3M | 108.38%990.2M | 106.82%915.6M | 104.84%875.7M | 118.58%895.3M | 118.58%895.3M | 258.64%475.2M | 247.76%442.7M | 286.18%427.5M |
Total non current assets | 50.67%12.94B | 50.67%12.94B | 76.89%12.44B | 72.79%11.19B | 76.89%10.63B | 74.65%8.59B | 74.65%8.59B | 58.51%7.03B | 58.78%6.48B | 54.27%6.01B |
Total assets | -0.87%22.53B | -0.87%22.53B | 2.37%22.24B | -1.07%20.13B | 26.05%23.92B | 25.23%22.73B | 25.23%22.73B | 30.05%21.73B | 30.59%20.35B | 33.10%18.97B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -5.07%877.6M | -5.07%877.6M | 5.29%395.8M | -9.67%327.9M | 8.73%351.4M | 43.96%924.5M | 43.96%924.5M | 196.22%375.9M | 83.33%363M | 86.18%323.2M |
-accounts payable | 13.18%413M | 13.18%413M | 5.29%395.8M | -9.67%327.9M | 8.73%351.4M | 20.07%364.9M | 20.07%364.9M | 196.22%375.9M | 83.33%363M | 86.18%323.2M |
-Total tax payable | 61.91%161.1M | 61.91%161.1M | ---- | ---- | ---- | -19.30%99.5M | -19.30%99.5M | ---- | ---- | ---- |
-Other payable | -34.04%303.5M | -34.04%303.5M | ---- | ---- | ---- | 114.00%460.1M | 114.00%460.1M | ---- | ---- | ---- |
Current accrued expenses | 1.65%2.36B | 1.65%2.36B | 10.75%3.22B | 13.16%2.94B | 20.20%2.8B | 29.62%2.32B | 29.62%2.32B | 28.39%2.91B | 22.58%2.6B | 35.19%2.33B |
Current debt and capital lease obligation | 10.27%92.3M | 10.27%92.3M | ---- | ---- | ---- | -6.38%83.7M | -6.38%83.7M | ---- | ---- | ---- |
-Current capital lease obligation | 10.27%92.3M | 10.27%92.3M | ---- | ---- | ---- | -6.38%83.7M | -6.38%83.7M | ---- | ---- | ---- |
Current deferred liabilities | 21.43%206.8M | 21.43%206.8M | ---- | ---- | ---- | 6.70%170.3M | 6.70%170.3M | ---- | ---- | ---- |
Other current liabilities | -38.07%31.4M | -38.07%31.4M | 13.09%357.6M | -28.57%279.3M | 72.04%648.6M | -18.88%50.7M | -18.88%50.7M | 45.05%316.2M | 63.80%391M | 31.77%377M |
Current liabilities | 0.48%3.56B | 0.48%3.56B | 10.38%3.97B | 5.82%3.55B | 25.43%3.8B | 29.37%3.55B | 29.37%3.55B | 37.95%3.6B | 31.14%3.35B | 38.80%3.03B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 128.67%1.66B | 128.67%1.66B | 128.67%1.7B | 21.60%933.4M | -8.60%721.3M | -10.56%724.7M | -10.56%724.7M | -9.69%744.7M | -9.41%767.6M | -9.55%789.2M |
-Long term capital lease obligation | 128.67%1.66B | 128.67%1.66B | 128.67%1.7B | 21.60%933.4M | -8.60%721.3M | -10.56%724.7M | -10.56%724.7M | -9.69%744.7M | -9.41%767.6M | -9.55%789.2M |
Other non current liabilities | 3.52%203.2M | 3.52%203.2M | 7.36%933.3M | 15.47%876.8M | 17.49%853.6M | -15.75%196.3M | -15.75%196.3M | 257.88%869.3M | 209.67%759.3M | 145.11%726.5M |
Total non current liabilities | 59.70%2.56B | 59.70%2.56B | 63.33%2.64B | 18.55%1.81B | 3.91%1.57B | 7.11%1.6B | 7.11%1.6B | 51.19%1.61B | 39.76%1.53B | 29.67%1.52B |
Total liabilities | 18.91%6.12B | 18.91%6.12B | 26.78%6.61B | 9.81%5.36B | 18.25%5.37B | 21.51%5.15B | 21.51%5.15B | 41.79%5.21B | 33.72%4.88B | 35.62%4.54B |
Shareholders'equity | ||||||||||
Share capital | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M |
-common stock | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M | 0.00%2.6M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -5.28%9.61B | -5.28%9.61B | -5.23%8.69B | -6.02%7.65B | 55.65%11.24B | 55.49%10.14B | 55.49%10.14B | 60.83%9.17B | 70.49%8.14B | 82.26%7.22B |
Paid-in capital | -10.43%6.67B | -10.43%6.67B | -5.91%6.91B | -3.64%7.1B | 0.89%7.28B | 0.86%7.45B | 0.86%7.45B | 1.58%7.34B | 3.79%7.37B | 4.18%7.22B |
Gains losses not affecting retained earnings | 993.71%127.8M | 993.71%127.8M | 1,060.00%28.8M | 156.53%22.5M | 232.06%17.3M | -1,887.50%-14.3M | -1,887.50%-14.3M | -103.07%-3M | -169.22%-39.8M | -215.93%-13.1M |
Total stockholders'equity | -6.66%16.41B | -6.66%16.41B | -5.34%15.63B | -4.50%14.77B | 28.51%18.55B | 26.36%17.58B | 26.36%17.58B | 26.73%16.51B | 29.64%15.47B | 32.32%14.43B |
Total equity | -6.66%16.41B | -6.66%16.41B | -5.34%15.63B | -4.50%14.77B | 28.51%18.55B | 26.36%17.58B | 26.36%17.58B | 26.73%16.51B | 29.64%15.47B | 32.32%14.43B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |